Sulfasalazine: My study [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-05-28 14:04 (1766 d 12:27 ago) – Posting: # 20304
Views: 2,981

Hi Irene,

❝ Have anyone here ever conducted Bioequivalence study of Sulfasalazine?


Yes. My results (T1: 1×4 500 mg IR, T2: 1×4 500 mg enteric coated, R: 2,000 mg suspension, six-sequence Williams’ design, sampling for 60 hours, washout two weeks, 24 eligible subjects, plasma and urine). This study was performed for the originator. Both test products showed lower bioavailabilities of sulfasalazine and 5-ASA, whereas sulfapyridine and N-acetylsulfapyridine were BE. CVs for plasma:Given the high variabilities of Sulfasalazine and 5-ASA I suggest reference-scaling.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
79 visitors (0 registered, 79 guests [including 8 identified bots]).
Forum time: 01:32 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5